Effect of antiandrogen treatment on chemical hepatocarcinogenesis in rats

B Matsuura1, Y Taniguchi, Y Ohta

  • 1Third Department of Internal Medicine, Ehime University School of Medicine, Japan.

Journal of Hepatology
|August 1, 1994
PubMed

Insights

Antiandrogen therapy significantly reduced liver tumor size and number in a rat model. This treatment also improved tumor differentiation and decreased cancer cell proliferation, suggesting potential for human hepatocellular carcinoma treatment.

Area of Science:

  • Oncology
  • Endocrinology
  • Hepatology

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern.
  • Androgen receptor signaling plays a role in liver cancer development.
  • Effective therapeutic strategies for HCC remain limited.

Purpose of the Study:

  • To investigate the efficacy of antiandrogen treatments in suppressing hepatocarcinogenesis.
  • To evaluate the impact of antiandrogens on tumor characteristics and cell proliferation.
  • To explore the role of androgen receptors in HCC progression.

Main Methods:

  • Utilized the Solt-Farber rat model for induced hepatocarcinogenesis.
  • Administered various antiandrogen treatments: orchiectomy, LH-RH analog, and chlormadinone acetate.
  • Assessed tumor size, number, differentiation, bromodeoxyuridine labeling index, and androgen receptor mRNA expression.

Main Results:

  • Antiandrogen treatments significantly reduced liver tumor size and number.
  • A decrease in poorly differentiated carcinomas and an increase in well-differentiated ones were observed.
  • Bromodeoxyuridine labeling index and androgen receptor mRNA expression in tumors were significantly reduced.

Conclusions:

  • Antiandrogen therapy demonstrates potent inhibitory effects on experimental liver cancer.
  • Orchiectomy and LH-RH analog showed the most significant tumor suppression.
  • These findings support the potential clinical application of antiandrogen therapy for human HCC.